BSX Approves Listing of ImuMed International Ltd.

Hamilton, Bermuda, January 10, 2000 - The Listing Committee of The Bermuda Stock Exchange (BSX) today announced the approval of the listing of 6,658,979 Common Shares (comprising 3,808,979 Shares already issued and outstanding; up to a maximum of 2,500,000 shares subject of ImuMed's offering; and 350,000 shares imbedded in the Company's option plans)of ImuMed International.

ImuMed International was incorporated and registered in Bermuda as an exempted Company on August 16, 1999.

ImuMed International is engaged in the business of providing blood grouping and serological products. Through its operating subsidiaries in Germany, ImuMed manufactures a broad range of blood grouping tests and serology products under the German Pharmacy Act, and provides them to 45 laboratories in Germany and Switzwerland, as well as 44 physicians located in Germany and Italy.

The listing of ImuMed International Ltd. is sponsored by First Bermuda Financial Services Limited. Barons Financial Services acted as Financial Advisor to ImuMed International Ltd.

The chairman, Eric F. Kohn, stated that, "He was pleased that the Company had been able to be listed on the BSX."

"The BSX is pleased to welcome ImuMed International Ltd. to listing", said Mr. James S. McKirdy, Listing Manager of the BSX.

For further information on ImuMed International Ltd., please contact Eric F. Kohn at telephone: 011-44-38-5301-500, facsimile: 011-41-22-798-9448 or email:efk@barons.ch.